Kemwell Biopharma increases capacity for manufacturing of biologics EP News Bureau Apr 27, 2021 The company has acquired an Ambr 250, added three single use bioreactors (SUBs) to support process scale-up, preclinical…
Notices issued to companies for introducing drugs without prior nod from NPPA: Government Press Trust of India Jul 25, 2019 The drugs include those used for treating conditions like diabetes, inflammation and chronic hepatitis C, among others
